B2i Digital Partners with ROTH Capital for Exclusive Healthcare Investment Conference
TL;DR
B2i Digital's partnership with ROTH provides exclusive access to 30 innovative healthcare companies, offering investors a strategic advantage in identifying high-growth opportunities before they become mainstream.
B2i Digital will leverage its network of 1.4 million market participants to facilitate structured 25-minute meetings and panel discussions between institutional investors and healthcare company executives.
This conference connects healthcare innovators with investors to accelerate treatments for conditions like leukemia and underserved indications, potentially improving patient outcomes and advancing medical progress.
The event features unique panels including an FDA expert roundtable and discussions on small firms tackling blockbuster medical indications, offering rare insights into healthcare innovation.
Found this article helpful?
Share it with your network and spread the knowledge!
B2i Digital, Inc. has been selected as Marketing Partner for the 4th Annual ROTH Healthcare Opportunities Conference, scheduled for October 8-9, 2025 at the Metropolitan Club in New York City. This partnership represents a significant development in the healthcare investment landscape, bringing together institutional investors with senior executives from approximately 30 innovative public healthcare companies across biotechnology, medical technologies, and pharmaceuticals.
The conference's importance lies in its exclusive, invitation-only format that facilitates deep engagement between investors and company management through structured 1-on-1 and small group meetings. These 25-minute sessions are specifically designed to foster meaningful dialogue and connections that can drive investment decisions in the healthcare sector. The event also features specialized panel discussions addressing critical industry topics including small firms tackling blockbuster indications, acute myeloid leukemia research, FDA regulatory insights, and innovation in underserved medical indications.
As Marketing Partner, B2i Digital will leverage its proprietary network of over 1.4 million market participants, including family offices, portfolio managers, and high-net-worth investors, to enhance attendance and visibility for presenting companies. David Shapiro, CEO of B2i Digital, emphasized the significance of this collaboration, stating that ROTH "quite literally wrote the playbook on investor conferences" and that his firm is "humbled to play a role in advancing that legacy." This partnership underscores the evolving nature of investor relations in the digital age, where strategic marketing partnerships can significantly impact a company's ability to connect with the right investment community.
The conference's focus on growth-oriented healthcare companies comes at a critical time for the industry, as innovation in biotechnology and medical technologies requires substantial capital investment. By providing a platform for targeted visibility and institutional-caliber exposure, this event addresses the fundamental challenge facing many healthcare companies: accessing the right investors who understand their specific market opportunities and growth potential. The partnership between B2i Digital and ROTH Capital Partners represents a maturation of how investor conferences leverage digital marketing expertise to enhance their impact and reach.
For the healthcare investment community, this collaboration signals an important trend toward more sophisticated, targeted approaches to connecting innovators with capital. The conference's structured format and B2i Digital's marketing capabilities combine to create an environment where meaningful investment relationships can develop, potentially accelerating the development of new medical technologies and treatments. More information about B2i Digital's services can be found at https://b2idigital.com, while details about ROTH Capital Partners are available at https://www.roth.com.
Curated from NewMediaWire
